Dr. Darren Freed is a cardiac surgeon clinician-scientist with an interest in heart and lung failure and novel techniques to treat these conditions. His primary clinical interests are in cardiothoracic transplantation and mechanical circulatory assistance as well as less invasive cardiac surgery. His primary research interests are in ex-vivo organ perfusion, heart transplantation, mechanical circulatory support and the biological basis of myocardial fibrosis. He obtained his MD from the University of Alberta in 1998 and completed his cardiac surgical training at the University of Manitoba where he also obtained a Ph.D in Physiology in 2004. In 2007 he completed a Clinical Fellowship in Cardiothoracic Transplantation and Ventricular Assist Devices at Papworth Hospital in Cambridge, United Kingdom. He is currently an Associate Professor, Division of Cardiac Surgery, Department of Surgery, with cross appointments in the Departments of Physiology and Biomedical Engineering. He is the Director of Research for the Alberta Transplant Institute.
Richard leads the product development team including electrical, mechanical, software and validation engineers. Key activities include defining the concept for new product development and specifications; supporting the team in designing, prototyping, and validating EVOSS; and defining and overseeing testing, validation, and transfer to production. Richard has worked in a multitude of high tech industries which have taken him to dozens of countries around the globe. His background in enterprise architecture, business transformation, application development, medical devices, and biotech have brought him work in complex projects spanning multiple countries and diverse user groups. Aside from technical work, he is involved in non-profit work and organizes a think tank to develop and support people's ideas for starting their own charitable organizations.
David graduated with his JD/MBA degree from the University of Toronto in 2001 and was called to the bar in 2002. In addition to the practice of law, David has co-founded and operated a successful software business and is active in federal politics. The ability to listen, absorb and synthesize facts and information and to break down complex issues to their core components is central to David’s approach to legal issues. He is known amongst his peers and clients for bringing novel approaches to difficult issues and reframing issues to create outside-the-box solutions and opportunities. In addition to business and the practice of law, David volunteers with and supports various non-profit and charitable organizations.
Dr. Jayan Nagendran is a cardiac surgeon clinician-scientist with an interest in end-stage lung disease and lung transplantation. The focus of his lab and clinical research is on the development and advancement of ex-vivo lung perfusion. He attended undergraduate and medical school at the University of Alberta, completing his MD in 2001. He joined the residency program in Cardiac Surgery at the University of Alberta from 2001-2009, and completed a Ph.D in Experimental Medicine during that time (2005-2008). After completing his cardiac surgical residency, Jayan sub-specialized in cardiothoracic transplantation surgery at Stanford University from 2009 to 2011. Dr. Nagendran’s pioneering roles in ex-vivo lung perfusion in Canada includes performing the first portable clinical ex-vivo lung perfusions in Canada. He created the second clinical ex-vivo lung perfusion program in Canada. He is the sole Canadian investigator of the largest international randomized controlled clinical trial examining the efficacy of ex-vivo lung perfusion compared to the standard of care (cold storage), the INSPIRE clinical trial. Dr. Nagendran is an Assistant Professor in the Department of Surgery and the Director of Research for the Division of Cardiac Surgery at the University of Alberta since 2011.
Carolyn is responsible for driving the business towards achieving its operational and strategic objectives by establishing partnership across R&D, Operations, Quality, Marketing and Finance. She takes a lead role in business plan creation, fund raising, device development, quality system implementation, operations, finance and commercialization. Carolyn's background is in operations, project management, business strategy, and technology commercialization. With a focus on health technologies, Carolyn has worked with dozens of companies to prepare for and launch innovative products into a demanding regulated marketplace.
Alexander Stickel B.Sc. P.Eng. graduated from the University of Alberta in 2004 with a B.Sc. in electrical engineering with a specialization in biomedical engineering. Prior to this, Alexander graduated in 2000 with a B.Sc. in Chemistry from The Kings University in Edmonton, Alberta, Canada. Alexander has over a decade of experience translating research equipment into commercial products. The bulk of which was in developing novel point of care medical diagnostic devices. From 2009 to 2011 Alexander participated in the Center for Point-of-Care Diagnostics initiatives sponsored by PATH, the University of Washington and the Bill and Melinda Gates foundation. This effort was to bring low-cost point-of-care medical devices to the global community. As the senior engineer at Tevosol, Alexander now joins immediately from one of the worlds foremost multinational technology developers.
Katie graduated from McGill University in 2014 with a BEng in Mechanical Engineering. In early 2015, Katie became the first engineering graduate student to join Dr. Darren Freed’s ex-vivo heart perfusion research team, a group that is developing the revolutionary “heart in a box” technology at the University of Alberta. With the guidance of a supervisory team with expertise in the Departments of Surgery, Physiology, Biomedical Engineering and Mechanical Engineering, Katie obtained an MSc in Biomedical Engineering in 2017. Her research focused on developing a compliant mock aorta for the ex-vivo heart perfusion system and experimentally determining its impact on cardiac performance. Katie joined the Tevosol team fresh out of her Masters ready to use her expertise to help bring this incredible technology to market.